日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Semi-Automated and Unbiased Microglia Morphology Analysis Following Mild Traumatic Brain Injury in Rats

大鼠轻度创伤性脑损伤后小胶质细胞形态的半自动无偏分析

Sumberg, Luke; Berman, Rina; Pazgier, Antoni; Torres, Joaquin; Qiu, Jennifer; Tran, Bodhi; Greene, Shannen; Atwood, Rose; Boese, Martin; Choi, Kwang

Engineered live bacteria suppress Pseudomonas aeruginosa infection in mouse lung and dissolve endotracheal-tube biofilms

工程活菌抑制小鼠肺中的铜绿假单胞菌感染并溶解气管插管生物膜

Rocco Mazzolini #, Irene Rodríguez-Arce #, Laia Fernández-Barat, Carlos Piñero-Lambea, Victoria Garrido, Agustín Rebollada-Merino, Anna Motos, Antoni Torres, Maria Jesús Grilló, Luis Serrano, Maria Lluch-Senar3

Driving pressure and adjunctive therapies in pulmonary sequelae of COVID-19 patients under invasive ventilation

有创通气下 COVID-19 患者肺部后遗症的驱动压及辅助治疗

Jessica González #, Iván D Benítez #, Anna Motos, Antoni Torres, Ferran Barbé; CIBERESUCICOVID Group

Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study

瑞德西韦与 COVID-19 危重患者的生存结果:一项多中心观察性队列研究

Catia Cillóniz, Anna Motos, Tatiana Castañeda, Albert Gabarrús, Ferran Barbé, Antoni Torres; CIBERESUCICOVID Project (COV20/0011, ISCIII)

IL-6 and cfDNA monitoring throughout COVID-19 hospitalization are accurate markers of its outcomes

COVID-19 住院期间的 IL-6 和 cfDNA 监测是其结果的准确指标

Salvador Bello, Ana Belén Lasierra, Lucía López-Vergara, Cristina de Diego, Laura Torralba, Pablo Ruiz de Gopegui, Raquel Lahoz, Claudia Abadía, Javier Godino, Alberto Cebollada, Beatriz Jimeno, Carlota Bello, Antonio Tejada, Antoni Torres

Engineering oncogene-targeted anisamide-functionalized pBAE nanoparticles as efficient lung cancer antisense therapies

设计针对致癌基因的茴香酰胺功能化 pBAE 纳米粒子作为有效的肺癌反义疗法

Cristina Fornaguera, Antoni Torres-Coll, Laura Olmo, Coral Garcia-Fernandez, Marta Guerra-Rebollo, Salvador Borrós

Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

指导 COVID-19 危重患者使用类固醇进行个性化治疗的主要候选变量:CIBERESUCICOVID 研究

Antoni Torres #, Ana Motos #, Catia Cillóniz, Adrián Ceccato, Laia Fernández-Barat, Albert Gabarrús, Jesús Bermejo-Martin, Ricard Ferrer, Jordi Riera, Raquel Pérez-Arnal, Dario García-Gasulla, Oscar Peñuelas, José Ángel Lorente, David de Gonzalo-Calvo, Raquel Almansa, Rosario Menéndez, Andrea Palome

One-year mortality after ICU admission due to COVID-19 infection

因 COVID-19 感染入住 ICU 后一年内死亡率

Adrian Ceccato, Raquel Pérez-Arnal, Anna Motos, Ferran Barbé, Antoni Torres; CiberesUCICOVID Consortium

Sleep and Circadian Health of Critical COVID-19 Survivors 3 Months After Hospital Discharge

出院 3 个月后危重 COVID-19 幸存者的睡眠和昼夜节律健康

Iván D Benítez, Anna Moncusí-Moix, Rafaela Vaca, Clara Gort-Paniello, Olga Minguez, Sally Santisteve, Paola Carmona, Gerard Torres, Juliane Fagotti, Gonzalo Labarca, Antoni Torres, Jessica González, David de Gonzalo-Calvo, Ferran Barbé, Adriano D S Targa

Label-Free Plasmonic Biosensor for Rapid, Quantitative, and Highly Sensitive COVID-19 Serology: Implementation and Clinical Validation

用于快速、定量、高灵敏度 COVID-19 血清学检测的无标记等离子体生物传感器:实施和临床验证

Olalla Calvo-Lozano, Miquel Sierra, Maria Soler, Maria Carmen Estévez, Luis Chiscano-Camón, Adolfo Ruiz-Sanmartin, Juan Carlos Ruiz-Rodriguez, Ricard Ferrer, Juan José González-López, Juliana Esperalba, Candela Fernández-Naval, Leticia Bueno, Ruben López-Aladid, Antoni Torres, Laia Fernández-Barat,